MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Tuesday, September 24, 2019

1:45pm-3:15pm
Evaluation of Clinical Peculiarities of Violations of Vertical Vision in Patients with Parkinson’s Disease

M. Salokhiddinov, D. Akramova (Tashkent, Uzbekistan)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Evaluation of Constipation in Patients with Parkinson’s Disease and its Correction

M. Salokhiddinov, D. Akramova (Tashkent, Uzbekistan)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Evaluation of dose rate of photobiomodulation (light) therapy in patients with Parkinson’s Disease: Double blind placebo-controlled pilot trial. Is there a dose frequency per week that influences quality of life, mobility and cognition?

J. Bullock-Saxton, L. Laakso, A. Lehn, F. Read, K. Harm, A. Gosling, S. Hardy, P. Newcombe, A. Nolan, E. Tune (Brisbane, Australia)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Examining level of hemoglobin in patients with parkinson’s disease and the role of hemoglobin level in the disease course

SH. Shohimardonov, K. Daminova (Tashkent, Uzbekistan)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Examining supplementary motor area-primary motor cortex connectivity in tremor-dominant Parkinson’s disease using a novel transcranial magnetic stimulation protocol to inform clinical practice

BK. Rurak, J. Rodrigues, B. Power, P. Drummond, AM. Vallence (Murdoch, Australia)

Neurophysiology  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Exercise and physical activity for people with Progressive Supranuclear Palsy

S. Slade, D. Finkelstein, J. Mcginley, M. Morris (Ivanhoe, Australia)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Exosomes from patients with Parkinson’s disease are pathological in mice

C. Han, N. Xiong, X. Guo, J. Huang, K. Ma, L. Liu, Y. Xia, S. Yin, L. Kou, F. Wan, J. Hu, G. Zhang, T. Wang (Wuhan, China)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Exploratory Analysis of Electrocortical Signal Complexity in Patients with Progressive Supranuclear Palsy and Corticobasal Degeneration

G. Mostile, L. Giuliano, R. Terranova, A. Luca, G. Donzuso, G. Portaro, C. Rascunà, V. Sofia, A. Nicoletti, M. Zappia (Catania, Italy)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Exploring the cognitive workload during a visual search task in Parkinson’s disease

M. Ranchet, J. Morgan, A. Akinwuntan, H. Devos (Kansas City, KS, USA)

Neurophysiology  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Expression analysis of candidate genes in a cell model of affected and unaffected THAP1 mutation carriers and controls

H. Baumann, M. Trilck-Winkler, M. Grosse, A. Münchau, V. Kostic, C. Klein, F. Kaiser, P. Seibler, K. Lohmann (Belgrade, Serbia)

Dystonia  ·  Les Muses Terrace, Level 3
  • «Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 69
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
        • Help & Support
        • About Us
        • Cookies & Privacy
        • Wiley Job Network
        • Terms & Conditions
        • Advertisers & Agents
        Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
        Wiley